Reports were selected in which both a patient and a control group had been investigated. Only data on the most commonly used autonomic tests (HR variation at rest, during deep breathing, following standing up, during a Valsalva manoeuvre, and blood pressure changes following standing up and during sustained handgrip) are presented. Reference = number of citation in present paper, PD = Parkinson's disease, HR = heart rate, BP = blood pressure, NP = not performed, DB = hyperventilation/deep breathing. Remarks concerning the separate investigations are: 1 = no effect L-dopa; 2 = no difference on off; 3 = no effect L-dopa; 4 = no effect L-dopa, no effect of severity, effect of duration on HR after HV; 5 = HR variability normal in recent onset PD, abnormal in advanced PD. BP after standing normal in recent PD, abnormal in advanced PD. BP after standing enhanced by L-dopa; 6 = PD investigated as control group for progressive supranuclear palsy; 7 = effect L-dopa on HR, no effect L-dopa on BP, effect of severity and duration on HR.
It has been established that patients with Parkinson's disease (PD) frequently have autonomic nervous system dysfunction. '-19 Although methods and results vary between studies, there is strong evidence that parasympathetic as well as sympathetic function may be impaired in PD. Table 1 summarises findings of earlier reports on autonomic function in PD, which included control data. Evidence of parasympathetic dysfunction include heart rate (HR) changes after standing up,14 1819 after forced breathing,9 101214 and after the Valsalva manoeuvre."311141518 Abnormal sympathetic function tests included abnormal blood pressure (BP) response to standing Up,6 815 1819 and to sustained handgrip.9 121419 The cause of autonomic dysfunction in PD may be PD related damage to areas known to be involved in autonomic regulation. Lewy bodies, sometimes associated with neuronal loss, can be found in preganglionic structures of the sympathetic as well as the parasympathetic nervous system: the spinal intermediolateral horns,20 21 the vagal dorsal motor nucleUS,20 22 23 Reports were selected in which both a patient and a control group had been investigated. Only data on the most commonly used autonomic tests (HR variation at rest, during deep breathing, following standing up, during a Valsalva manoeuvre, and blood pressure changes following standing up and during sustained handgrip) are presented. Reference = number of citation in present paper, PD = Parkinson's disease, HR = heart rate, BP = blood pressure, NP = not performed, DB = hyperventilation/deep breathing. Remarks concerning the separate investigations are: 1 = no effect L-dopa; 2 = no difference on off; 3 = no effect L-dopa; 4 = no effect L-dopa, no effect of severity, effect of duration on HR after HV; 5 = HR variability normal in recent onset PD, abnormal in advanced PD. BP after standing normal in recent PD, abnormal in advanced PD. BP after standing enhanced by L-dopa; 6 = PD investigated as control group for progressive supranuclear palsy; 7 = effect L-dopa on HR, no effect L-dopa on BP, effect of severity and duration on HR.
locus coeruleus, the raphe nuclei, the parabrachial area, various other pontine and mesencephalic structures, and the hypothala- Thirty one age-matched controls were selected from a database of healthy subjects,29
and studied with the same battery of tests.
Age of the controls (mean 65 1 [13.5] years, range 42-90) did not differ from that of PD patients (two sided t test, p = 0-91). PD patients were studied before, during, and after the period in which the controls were tested. The study was approved by the hospital's medical ethics committee, and the subjects gave informed consent.
AUTONOMIC TESTS
Autonomic nervous function was investigated as previously described.'929-31 Four mainly parasympathetic tests were applied; HR variation at rest, during forced breathing at 6-8 breaths per minute, following active standing up (modified 30:15 ratio), and during a Valsalva manoeuvre. ECG R-R intervals were measured by computer, converted to frequencies, and the difference (beats/min) between the maximum and the minimum frequencies during each test was noted. Differences rather than ratios were chosen to describe heart rate changes, because differences are less subject to influences of the resting heart rate.29 Two mainly sympathetic tests were applied: the BP response to actively standing up was quantified as the largest drop in systolic and diastolic pressure (mm Hg) 1 or 2 minutes after standing up. The largest increases in systolic and diastolic pressure during a 5 minute period of sustained hand grip (or until the subjects gave up) at 30% of maximum voluntary force were also noted. The mean HR at rest was noted, as were baseline BPs.
STATISTICAL ANALYSIS
The two sided t test (allowing for unequal variances), analysis of variance, or X2 tests were applied to investigate differences. Multivariate analysis of covariance was used to study differences in relationships with age between PD patients and controls. Bivariate regression and stepwise forward multiple regression techniques were applied to analyse the dependence of autonomic tests on clinical variables. Results of linear regression are presented with p values as well as with the percentage of variance explained by a relationship, expressed as the squared correlation coefficient multiplied by 100 (100R2). A p = 0-05 significance threshold was applied for all tests. Analyses were performed using the statistical packages NCSS (Kaysville, UT) and SPSS (Chicago, IL).
The analysis was performed at different levels. First of all, results of the eight autonomic function variables (four HR tests and both diastolic and systolic pressures of the two BP tests) were compared between the PD and control groups. Secondly, the influences of age and of the three PD related variables (that is, duration of disease, use of anti-Parkinson medication, and disease severity (HY) on autonomic function were investigated in the PD group. Thirdly, an attempt was made to disentangle the effects of these variables on autonomic function, but before this, the interrelations between these variables were assessed. For all eight autonomic variables, two physiological variables (age and either baseline BP or HR) and the three PD related variables were selected for possible inclusion in a stepwise forward regression analysis. Baseline HR or BP was included because these variables can influence autonomic responsiveness.29 Systolic BP was included when systolic changes were studied, and diastolic BP was included when diastolic changes were studied.
Results

DIFFERENCES BETWEEN PD AND CONTROL SUBJECTS
Characteristics of the PD and control groups are summarised in Relationships of autonomic variables and age (in years) were assessed using bivariate linear regression. The variables a and b refer to the formula of the line of best fit y = ax + b. 'p' Refers to the significance of the relationship within each group, expressed as in Table 2 . "IOOR2' describes the percentage of variance of an autonomic variable which is explained by age. Abbreviations as in Table 2 . Table 2 ) refer to ANOVA. Abbreviations as in Table 2 .
medication were in higher HY stages (p = 0 01). Although the age-medication relationship proved to be non-significant, the mean age of non-medicated patients was lower than that of medicated patients (63-3 A smaller degree of overall variance could be explained for the BP tests than for the HR tests. Two factors emerged as significant influences on the diastolic rise in the sustained handgrip test: age and baseline BP. The systolic rise in the same test was only influenced by use of medication. In the standing up test, HY stage influenced both systolic and diastolic BP changes.
Although the use of anti-Parkinson medication was considered to be a PD related variable, the relation is iatrogenic rather than pathophysiological in nature. In view of the importance of medication for autonomic function, the unmedicated PD group was compared with the control group. Age did not differ significantly between the unmedicated PD (63-3 years) and the control (65-1 years) groups. None of the autonomic tests showed significant differences between these groups. A tendency towards significance (p = 0 08) was found for the fall in diastolic BP on standing. Within this unmedicated PD group, relationships with age and baseline HRs or BPs were similar to those for the entire PD group. However, no convincing correlations with clinical severity or disease duration could be found. Table S Forward stepwise regression analysis Step 1
Step 2 Step group: p = 0 01), and short duration (2-0 [1 9] years, compared with 4-8 years of the medicated PD group: p = 0-002). The results of this study suggest that autonomic dysfunction is limited to the BP response to standing up, that this is restricted to more severe PD, and even then remains modest in severity. As such, our findings strengthen Bannister's conclusion regarding the paucity of cardiovascular autonomic dysfunction in PD32 with detailed evidence.
The evaluation of cardiovascular autonomic dysfunction in PD is easily confounded by interrelated variables, the most important being age and the use of antiParkinson medication. A failure to compensate for such factors may lead to the erroneous conclusion that the frequently occurring disturbance of autonomic tests in PD is entirely due to PD, whereas PD itself appears to cause only modest damage to the antonomic nervous system.
